Lockheed Martin Investment Management CO Vertex Pharmaceuticals Inc Transaction History

Lockheed Martin Investment Management CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$207.02 - $241.31 $5.03 Million - $5.87 Million	-24,320 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $1.76 Million - $2.35 Million	8,500 Added 53.73%	24,320 $5.75 Million
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $4.04 Million - $4.8 Million	15,820 New	15,820 $4.3 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $5.64 Million - $6.35 Million	-33,950 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $3.12 Million - $3.61 Million	18,950 Added 126.33%	33,950 $6.23 Million
Q1 2019 May 10, 2019	BUY	$163.73 - $194.7 $2.46 Million - $2.92 Million	15,000 New	15,000 $2.76 Million
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $687,693 - $790,234	-4,100 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$145.72 - $169.96 $174,864 - $203,952	-1,200 Reduced 22.64%	4,100 $697,000
Q1 2018 Apr 26, 2018	BUY	$151.6 - $177.13 $803,480 - $938,789	5,300 New	5,300 $0

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Lockheed Martin Investment Management CO, based on Form 13F filings with the SEC.

Stay updated on Lockheed Martin Investment Management CO with notifications on news.